09/29/2003

 


OIG Tackles Discount Issues Raised by New Health Care Economy

Robert E. Mazer
410-347-7359
remazer@ober.com

The Medicare and Medicaid discriminatory billing prohibition, enacted originally in 1972, provides for the potential exclusion from any federal health care program of an individual or entity which "has submitted or caused to be submitted bills or requests for payments . . . [under Medicare or Medicaid] containing charges . . . for items or services furnished substantially in excess of such individual's or entity's usual charges . . ., unless the Secretary finds there is good cause . . . ."

Application of this prohibition has always been uncertain. The level of uncertainty increased dramatically after the marketplace required hospitals and other health care providers to accept payments from insurers and managed care organizations that were substantially less than Medicare and Medicaid payment amounts. Additionally, "charges" — the principal focus of the statutory prohibition — became far less relevant in the determination of third-party payments, which were limited increasingly by fee schedules. The OIG has issued a notice of proposed rulemaking that attempts to reconcile these changes with the long-standing Medicare/Medicaid discriminatory billing prohibition and provides for federal programs to share benefits from negotiated discount arrangements. 68 Fed. Reg. 53,939 (Sept. 15, 2003).

Discriminatory Billing Prohibition
The OIG proposes to make the discriminatory billing prohibition inapplicable to physician services reimbursed under the Medicare physician fee schedule, finding that that fee schedule reflects congressional direction and is the functional equivalent of a prospective payment methodology. The discriminatory billing prohibition would continue to apply to clinical laboratory tests, durable medical equipment, medical supplies and drugs and other items and services, even though payments might be subject to fee schedules.

According to the OIG, generally, when a provider's usual charge to most of its customers for a service drops substantially below a Medicare fee schedule, but Medicare continues to be billed an amount which is equal to or more than the fee schedule amount, the provider has an unlawful two-tiered pricing structure. Unless costs "uniquely associated with the Medicare program" justify the charge differential, a provider would either have to reduce its charges to Medicare and Medicaid or risk exclusion from federal health care programs. Under the proposed rule, the OIG would not require that Medicare and Medicaid receive a provider's best price. However, the OIG would not permit Medicare and Medicaid to become among the few payors that do not benefit from health care competition and resulting discount arrangements.

The proposed rule includes several new policies, most of which are intended to provide Medicare and Medicaid with financial benefits from arrangements that have been negotiated by managed care organizations and other health care payors. These policies could present a serious dilemma for health care providers who are frequently required to accept discounted payment rates under managed care contracts. They could be forced to reduce their charges to Medicare and Medicaid or refuse managed care contracts that provide for deeply discounted payments.

Charges Included in "Usual Charge" Calculation
The proposed rule includes, by far, the most detailed guidelines regarding the calculation of a provider's "usual charge" that have ever been published. The OIG states that the computation should include charges to cash-paying patients, charges to patients covered by indemnity plans with which the provider does not have a participation contract, and fee-for-service payment rates specified in a contract with a managed care plan or other payor. It would appear that a laboratory's charges to physicians and other health care providers under "client bill" arrangements would be included in the usual charge calculation. The usual charge calculation would not include free or substantially reduced charges for uninsured individuals; capitated payments; fees paid generally by Medicare and most other federal and state health insurance plans; and rates under hybrid fee-for-service plans where more than 10 percent of the maximum payments are tied to a bonus or withhold provision.

In computing a health care provider's usual charge, the OIG would consider charges of affiliated entities subject to common control if they provide substantially the same items and services in the same or substantially the same markets. This could require consideration of a hospital's charges in determining whether a related clinical laboratory or diagnostic imaging center has violated the discriminatory billing prohibition, for example. It is uncertain whether the OIG would permit different charge structures in different geographic markets only, or whether it might recognize other markets, for example, for services to hospital inpatients, hospital outpatients, and non-hospital patients.

Usual Charge Calculation
Generally, in determining a provider's usual charge, the amount the provider was expected to receive would be considered. The amount charged to patients would be used when there was a good faith effort to collect that amount. Similarly, the calculation would reflect the amount charged when a provider billed a health plan with which it did not have a contract, reflecting amounts anticipated to be collected both from the plan and from the insured. However, the discounted payment rate would be used when services were furnished under a contract with a managed care plan or other payor, plus any applicable copayment. The submitted charge would not be used when the contract provided for lower payment rates, such as payments based on a specified fee schedule. Where a contract provides for payment of a bonus or withhold amount equal to 10 percent or less of total compensation, one-half of the potential bonus or withhold payment would be included in the usual charge calculation.

The provider's usual charge would be the mean or median of these charges — the charge at which 50 percent of the charges are below and 50 percent of the charges are above (the OIG is considering both approaches). Therefore, close attention would be required by any provider which expected to receive less than the Medicare/Medicaid fee schedule nearly one-half of the time it furnished services under arrangements that are relevant to the usual charge calculation, including under managed care contracts.

Substantially in Excess Standard
The proposed rule would severely limit the level of discount that a health care provider might offer without potentially being required to provide Medicare and Medicaid a similar payment rate. A provider's charge to Medicare or Medicaid will be considered "substantially in excess of [its] usual charges" — calculated as stated above — if it is more than 120 percent of the provider's usual charge. Thus, only discounted payment rates that are within 20 percent of Medicare and Medicaid payment amounts would escape scrutiny.

Where payments will be limited by a fee schedule, the lower of the fee schedule amount and the submitted charge would be compared with the calculated usual charge in determining whether the discriminatory billing prohibition has been violated. For example, where Medicare pays the lower of the submitted charge of $100 or fee schedule amount of $50, the lower fee schedule amount of $50 would be compared to the provider's usual charge.

OIG Discretion
The OIG indicates that it may find good cause for charging substantially more than the usual charge based on increased costs associated with services to Medicare/Medicaid beneficiaries, for example, claims processing delays or denials. However, if the OIG requires providers to demonstrate that their profit margin on services sold to Medicare or Medicaid is no greater than that earned from sales under negotiated managed care contracts, this good cause exception may be of little use to many providers.

The burden of proving good cause will be on the provider furnishing the services, and the OIG's determination will not be subject to review. The OIG also states that it is not required to exclude a provider that has violated the statutory prohibition. According to the OIG, it would not exclude providers for isolated or unintentional mistakes. The OIG's substantial discretion is likely to provide little comfort to health care providers which have been required to offer items and services under deeply discounted payment arrangements.

Conclusion
The proposed rule addresses an issue of vital importance to many health care providers. The discriminatory billing prohibition has lain virtually dormant over a 30-year period, partly because the statute's use of vague, undefined terms such as usual charges and substantially in excess makes enforcement actions difficult. Final regulations defining these terms would remove that bar.

If the proposed policies are adopted as a final rule, health care providers with substantial managed care or other discount arrangements could be required to reevaluate their current business model. A provider may be required to limit the managed care arrangements in which it participates or the discounts it provides to those plans, or offer those same discounts to Medicare and Medicaid.

A proposed rule does not have any legal authority. However, the OIG could assert that certain aspects of the proposed rule reflect policies that are currently in effect under the existing statute and regulations.

It is unknown if and when a final rule will be adopted. Additionally, the final rule could be significantly different from the proposed rule. Until publication of a final rule, providers will be required to make important business decisions based on limited information currently available.

 

 

 

Ober, Kaler, Grimes & Shriver

Maryland
120 East Baltimore Street, Baltimore, MD 21202
Telephone 410-685-1120, Fax 410-547-0699

Washington, D.C.
1401 H Street, NW, Suite 500, Washington, DC 20005
Telephone 202-408-8400, Fax 202-408-0640

Virginia
407 North Washington Street, Suite 105, Falls Church, VA 22046
Telephone 703-237-0126, Fax 202-408-0640